Lymphoma  >>  RET inhib  >>  Phase 2
Welcome,         Profile    Billing    Logout  

Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials		 02468101214161820
            
            
             
sunitinib / Generic mfg.           
          
            
             
sorafenib / Generic mfg.           
          
            
             
Focus V (anlotinib) / Advenchen, Sino Biopharm           
          
            
             
Balversa (erdafitinib) / J&J           
          
            
             
Iclusig (ponatinib) / Takeda, Otsuka           
          
            
             
Retevmo (selpercatinib) / Eli Lilly           
          
            
             
Stivarga (regorafenib) / Bayer